NCT07122856 · NOT YET RECRUITING

Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients

This is an observational study — no treatment is being tested. Researchers at a French memory clinic are reviewing medical records to identify which factors, such as age, education, nutrition, and mood, are linked to how well Alzheimer's patients score on a standard cognitive test at diagnosis and how quickly that score drops over 12 months. The goal is to understand what drives early decline, which could help doctors plan better care.

You may qualify if

  • Confirmed diagnosis of Alzheimer's disease according to NIAA 2018 or IWG 2021 criteria
  • At least two MMSE evaluations spaced 12 months apart
  • Follow-up at the Memory Clinic of CH Gonesse

You're excluded if

  • Presence of other neurodegenerative diseases (e.g., Frontotemporal Dementia, Multiple System Atrophy, Vascular Dementia, LATE)
  • Patient has moved out of the study area (outside the CH Gonesse territory)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-14

View full record on ClinicalTrials.gov

All APOE4 clinical trials